Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-012497
Filing Date
2015-03-18
Accepted
2015-03-18 16:58:09
Documents
1
Period of Report
2015-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 9126
  Complete submission text file 0001140361-15-012497.txt   11228
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1881 GROVE AVENUE RADFORD VA 24141
Business Address
KIRK RANDAL J (Reporting) CIK: 0001091823 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23930 | Film No.: 15710659

Mailing Address 1750 KRAFT DRIVE SUITE 1400 BLACKSBURG VA 24060
Business Address 1750 KRAFT DRIVE SUITE 1400 BLACKSBURG VA 24060 301-556-9809
INTREXON CORP (Reporting) CIK: 0001356090 (see all company filings)

State of Incorp.: VA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23930 | Film No.: 15710658
SIC: 8731 Services-Commercial Physical & Biological Research